Targeting cyclooxygenase2 for prevention and therapy of colorectal cancer

FA Sinicrope - … : Published in cooperation with the University of …, 2006 - Wiley Online Library
… COX-2 inhibitors have been reported to effectively prevent … role of COX-2 as a target for
the prevention and treatment of … Interest in cyclooxygenase (COX) as a therapeutic target for …

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

K Subbaramaiah, AJ Dannenberg - Trends in pharmacological sciences, 2003 - cell.com
… selective inhibitors of COX-2 are effective in the prevention and treatment of cancer. …
that cyclooxygenase 2 (COX-2) is a bona fide pharmacological target for anti-cancer therapy. …

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer

LR Howe, AJ Dannenberg - Seminars in oncology, 2002 - Elsevier
Cyclooxygenase-2 (COX-2) is being intensively evaluated as a pharmacologic target for
both the prevention and treatment of cancer. Aberrant COX-2 expression was initially described …

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.

LR Howe, K Subbaramaiah, AM Brown… - Endocrine-related …, 2001 - erc.bioscientifica.com
… Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S & DuBois RN 1994 Up-regulation
of cyclooxygenase 2 gene expression in human colorectal adenomas and …

Cyclooxygenase-2 in oncogenesis

MT Rizzo - Clinica chimica acta, 2011 - Elsevier
… and therapy … of cyclooxygenase-2 inhibitors in adjuvant chemotherapy. Therefore, our ability
to efficiently target the oncogenic effects of cyclooxygenase-2 for therapeutic and preventive

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer

AJ Dannenberg, NK Altorki, JO Boyle, C Dang… - The lancet …, 2001 - thelancet.com
cyclooxygenase 2 (COX 2), an inducible form of the enzyme, is a potential pharmacological
target to prevent … Key data implicating a causal relation between increased activity of COX 2

The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis

RF Jacoby, K Seibert, CE Cole, G Kelloff, RA Lubet - Cancer research, 2000 - AACR
… Thus, our data indicate that COX-2-inhibitory drugs have therapeutic effects in addition to
acting via preventive mechanisms. In this regard, stereomicroscopic examination of the …

Cyclooxygenase-2: a therapeutic target

ME Turini, RN DuBois - Annual review of medicine, 2002 - annualreviews.org
… , and cardiovascular diseasesand now are under consideration for the prevention of colon
cancer and AD.COX-2 selective agents appear to be an improvement over conventional …

Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point

N Arber - Cancer Epidemiology Biomarkers & Prevention, 2008 - AACR
… in all the different subgroups in all three COX-2 inhibitor studies. These data suggest that 1
year of therapy might be sufficient to prevent polyp recurrence. Given that it is quite possible …

Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy

R Benelli, R Venè, N Ferrari - Translational Research, 2018 - Elsevier
A plentiful literature has linked colorectal cancer (CRC) to inflammation and prostaglandin-endoperoxide
synthase (PTGS)2 expression. Accordingly, several nonsteroidal …